Keros Therapeutics | 8-K: Current report
Keros Therapeutics | 8-K: Current report
Keros Therapeutics | 8-K: Current report
Keros Therapeutics | 8-K: Current report
Keros Therapeutics | 8-K: Current report
Keros Therapeutics | 8-K: Current report
Keros Therapeutics | 8-K: Current report
Keros Therapeutics | 8-K: Keros Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results
Keros Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Keros Therapeutics | DEFA14A: Others
Keros Therapeutics | DEF 14A: Definitive information statements
Keros Therapeutics | 8-K: Current report
Keros Therapeutics | 8-K: Current report
Keros Therapeutics | 8-K: Current report
Keros Therapeutics | 8-K: Current report
Keros Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Keros Therapeutics | 8-K: Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
Keros Therapeutics | 8-K: Current report
Keros Therapeutics | 8-K: Current report
Keros Therapeutics | 8-K: Current report
No Data